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Abstract 
Purpose: Tumor infiltrating lymphocytes (TILs) are known to correlate with 
the prognosis of patients affected by a variety of cancer types. We evaluated 
TILs in patients who underwent surgery for lung squamous cell carcinoma 
(SCC). 
Methods: Specimens resected from patients during resection of lung SCC 
were examined for TIL density, lymphoid follicle formation, expression of 
PD-L1, and appearance of regulatory T cells (Tregs). 
Results: We enrolled 72 patients who underwent surgery for SCC (TIL grade 
0, 1, and 2; 29, 18, and 25, respectively). Lymphoid follicles were observed in 
13 (18.1%) and 8 were positive for Tregs, which were always observed in 
association with lymphoid follicles (p<0.001). Multivariate analysis revealed 
that lymphoid follicle formation, appearance of Tregs, pathological stage, 
and pleural invasion were independent prognostic factors related to overall 
survival, whereas TIL density and PD-L1 expression were not. 
Conclusion: SCC patients with lymphoid follicle formation accompanied by 
 4 
Tregs show worse survival following lung resection surgery. 
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Introduction 
In the pat decades, most of the advances in the treatment of non-small 
cell lung cancer (NSCLC) have focused on adenocarcinoma or non-squamous 
cell carcinoma, while there have been no breakthrough in the treatment of 
squamous cell carcinoma (SCC). Recently, use of immune checkpoint 
inhibitor (ICI) therapy has drastically changed treatment options for 
patients with NSCLC, especially SCC. ICI administration blocks tumor 
immunoediting, and induces tolerance between cancer cells and the immune 
system, thus affecting the interaction between the programmed death (PD)-1 
pathway and its ligand (PD-L1). Several reports have suggested that 
tumor-infiltrating lymphocytes (TILs) are correlated with the prognosis of 
patients with various types of cancer, such as melanoma (1), colon (2), 
ovarian (3), breast (4), and pancreatic (5). Furthermore, TILs play a 
complementary role for TNM classification, and TIL density or distribution 
is associated with lung cancer prognosis (6). Another study found that the 
appearance of lymphoid follicles in tumor stroma is a possible prognostic 
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factor (2), though also noted that some reports reported favorable prognosis 
for patients with lymphoid follicles in tumor stroma, while others did not (2). 
In the present study, we focused on the patients with resectable lung 
SCC, and retrospectively analyzed the relationship between pathological 
factors, including TIL density, lymphoid follicles and the expression of 
PD1/PDL1 in tumor stroma, and prognosis of the patients in order to find 
prognostic markers to guide treatment.  
 
Methods 
Specimens resected from consecutive lung SCC patients who 
underwent a complete resection procedure from January 2010 through 
December 2012 at our institution were investigated. Informed consent for 
use of the materials was obtained from each patient and the Ethical 
Committee of Dokkyo Medical University Hospital approved this 
retrospective study (#R-5-8). Follow-up examinations were completed for all 
patients by January 2018.  
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Resected specimens were fixed in 10% neutral buffered formalin at 
room temperature, then embedded in paraffin. Sections (2 µm thick) were 
obtained from a block including the largest cut surface of the tumor, then 
stained with hematoxylin and eosin (H&E), and examined. Next, 4-µm thick 
sections were cut from the same blocks, and deparaffinized in xylene and 
dehydrated in graded alcohol solutions. A standard avidin-biotin complex 
peroxidase technique was then used for immunohistochemical staining of 
primary antibodies against CD3, CD4, CD8, CD20, and CD25. Trained 
observer (MN) and pathologists (YN) reviewed each slide in detail. When 
there is any disagreement, other pathologists (MK and HK) were introduced 
in. PD-L1 analysis of the blocks was performed by LSI Medience Corp. 
(Tokyo, Japan) using a commercially available antibody (22C3).  
Grading of TIL was divided into 3 grades based on intensity and 
distribution, with low or focal intensity given a grade of 0, medium or 
multi-focal intensity a grade of 1, and high or diffuse intensity a grade of 2 
(Figure 1A-C). Lymphoid follicles were identified as CD20-positive B cell 
 8 
accumulations with a germinal center (Figure 1D-F). The T cell/B cell ratio of 
TILs was determined based on CD3/CD20 ratio. CD4 and CD25 
double-positive T cells in TILs were considered to be infiltration by 
regulatory T cells (Tregs) (Figure 1G-I). 
Statistical analysis of the groups was performed using a chi-square test 
or Fischer’s exact test to compare variables. Survival curves were obtained 
using the Kaplan-Meier method and comparisons within each group were 
performed using a log-rank test. Risk factors for overall survival were 
evaluated with univariate and multivariate analyses using the Cox 
regression method. Statistical calculations were performed using the SPSS 
statistics version 25 software program (IBM Corp., NY, USA). Significance 
was considered at p<0.05. 
 
Results 
A total of 72 patients with SCC underwent a lung resection procedure 
during the study period. Patient characteristics are shown in Table 1. Nine 
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out of 72 patients underwent neo-adjuvant therapy before surgery, 
chemoradiotherapy in 5 and chemotherapy in 4. PD-L1 expression was 
measured in all, with data from 63 available, which showed 0% in 19 and  
≥1% in 44. Twenty-four patients had a postoperative complication, 
respiratory morbidity was in 19, pneumonia in 7, prolonged air leakage in 6, 
acute exacerbation of interstitial pneumonia in 4, and broncho-pleural 
fistula in 2; cardiovascular was in 4, arrhythmia in 2 and heart failure in 2; 
and surgical site infection was in 1. During the 5-year follow-up period, 31 of 
the patients died, 18 due to lung cancer and 13 to other causes, including 
pneumonia in 4, cardiovascular disease in 2, empyema in 2, interstitial 
pneumonia in 1, liver cirrhosis in 1, and unknown in 3. 
Among the 72 patients, a TIL grade of 0 was noted in 29, a grade of 1 
was noted in 18, and a grade of 2 was noted in 25. Lymphoid follicles were 
observed in 13 (18.1%) of the 72 cases. Tregs were positive in 8 cases and 
exclusively observed in tumors of patients with lymphoid follicles (p<0.001) 
(Table 2). The relationship between lymphoid follicles and PD-L1 expression 
 10 
is shown in Table 2, though the correlation was not statistically significant 
(p=0.16). 
Univariate analysis was performed using each factor (Table 3). Those 
results revealed that pathological stage, pleural invasion, vascular invasion, 
and lymphoid follicles were associated with overall survival after lung 
resection, while neo-adjuvant therapy, postoperatibe complication, TIL 
grade, and PD-L1 were not correlated with survival. Multivariate analysis 
was conducted with a p-value of <0.05 in univariate analysis, and revealed 
that pleural invasion and lymphoid follicles were independent prognostic 
factors related to overall survival in patients who underwent lung resection 
(Table 3). The 5-year survival rate for patients positive for pleural invasion 
was 42.3%, while that was 57.8% for those negative for that factor (Figure 
2A), a statistically significant difference (p=0.008). Furthermore, the 5-year 
survival rate for patients positive for lymphoid follicles was 19.2% and 60.5% 
for patients without those follicles (Figure 2B), p=0.002. As for Tregs, the 
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5-year survival rate was 18.8% and 58.3% in patients positive and negative, 
respectively (p=0.003) (Figure 2C). 
 
Discussion 
In the present study, we evaluated TIL density and lymphoid follicles in 
tumor stroma to determine their effectiveness as prognostic factors in 
patients with lung SCC after undergoing surgery. Our results indicate that 
lymphoid follicles, appearance of Tregs, pathological stage, and pl factor are 
independent prognostic factors related to overall survival following resection 
of lung SCC, while TIL density and PD-L1 expression were not associated 
with survival. In the present patients, Tregs were exclusively observed in 
cases with the presence of lymphoid follicles. 
TILs exist around cancer cells and play an important role in the 
mechanism of cancer immunity (7), while several reports have pointed out 
relationships of TIL subsets, such as CD3-, CD8-, and FOXP3-positive cells, 
with prognosis (8-11). Cancer cells that escape from the immune check-point 
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system because of down-regulation of the Fas/Fas-ligand pathway (12) lead 
to cancer growth due to inactivation of CD4- and CD8-positive lymphocytes, 
and avoid cytotoxic T cell attacks and apoptosis. We evaluated CD4 and CD8 
density as parameters of TIL subsets in the present specimens, but did not 
find their density or distribution to be a prognostic factor except Treg 
existence. Hasegawa and colleague reported prognostic value of Treg in 
NSCLC (13). We speculate that the existence of Treg is more important to 
the prognosis than quantity of TIL as shown in CD4- and CD8- positive cells. 
Studies related to colon cancer have noted observations of lymphoid 
follicle formation in advanced stage patients and that the prognosis of those 
with lymphoid follicles was superior as compared to those without (14-16). 
The presence of lymphoid follicles has been termed a Crohn’s-like lymphoid 
reaction and a germinal center occurs with lymphocyte accumulation. The 
existence of these follicles has been proposed to be a prognostic factor 
independent of stage and TIL (17-19). In the present study, we considered 
that CD20-positive B lymphocyte accumulation with a germinal center was 
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evidence of lymphoid follicles and their existence in patients with lung SCC 
indicated poor prognosis as compared to those without those follicles. In 
present study, all Treg positives had lymphoid follicles in their specimens. 
Because Treg existence is an indicator of worse prognosis in resected cancer 
(x), Treg existence around lymphoid follicle may affect the survival in 
present series. Further case accumulation and analysis will be necessary to 
explain the difference between our data and other references. 
FoxP3 is a specific marker of CD4 and CD25 double-positive Tregs, 
while Tregs have a role in suppression and regulation of immune response, 
as well as prevention of autoimmune disease (20). The existence of Tregs in 
TILs has been reported to be correlated with poor survival of patients with 
melanoma (21), kidney (22), breast (23), and ovarian (24), while those with 
Hodgkin lymphoma showed superior survival (25). In colon cancer, the role 
of Tregs has not been consistently elucidated (26). For example, a study 
found that tumor-infiltrating Tregs were associated with recurrence in 
pathologic stage I NSCLC patients (27), while another reported that lung 
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cancer patients with a high density of tumor-infiltrating Tregs had better 
prognosis as compared to those without Tregs (28). In the present study, we 
defined CD4 and CD25 double-positive lymphocytes as Tregs. Those were 
only found to exist around lymphoid follicles and all patients with Tregs had 
lymphoid follicle formation. We speculate that Tregs may suppress the 
immune response of lymphoid follicles, leading to worse prognosis for 
patients with those follicles present. 
Patients who undergo resection of advanced lung cancer often 
experience recurrence. Unfortunately, therapy options for recurrent disease 
are limited, especially lung SCC. Recently, the utility of ICI targeting PD-1 
or its ligand PD-L1 has been reported, and PD-L1 expression seems to be a 
biomarker of the effects of ICI. In present series, enrolled patients were 
operated from 2010 to 2012, and they did not undergo ICI therapy during 
postoperative course. We considered whether PDL1 expression itself affected 
survival without ICI therapy or not. An elevated expression of PD-L1 is 
associated with worse outcome of patients with bladder and ovarian cancer 
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(29, 30), while NSCLC patients with PD-1 expression have also been shown 
to have a worse prognosis (31, 32). In our study, PD-L1 expression itself was 
not a prognostic factor for patients with lung SCC following surgery and also 
not correlated with lymphoid follicle formation. 
Limitations of this study include its retrospective study design, 
performance by a single institution, and the small number of cases. 
Additional case accumulation is needed for analyzing the effects of TILs and 
lymphoid follicles on tumor-immune interaction in cases of lung SCC. 
 In conclusion, lymphoid follicle formation, appearance of Tregs, and 
pleural invasion were independent prognostic factors related to survival 
following resection of lung SCC, while TIL density and PD-L1 expression 
were not. 
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Figure legends 
Figure 1. Representative images showing tumor-infiltrating lymphocytes 
(TILs). A. Grade 0 (HE stain, x40). B. Grade 1 (HE stain, x100). C. Grade 2 
(HE stain, x100). D. Lymphoid follicles in tumor stroma (HE stain, x40). E. 
Lymphoid follicles with a germinal center (HE stain, x200). F. Lymphoid 
follicles composed of B cells (CD20 stain x100). G. T cells (CD4 stain, x40). H. 
B cells (CD20 stain, x40). I. Regulatory T cells (CD25 stain, x200). 
 
Figure 2. Overall survival curves. A. Relationship between pleural invasion 
and overall survival. Solid line, negative for pleural invasion; dotted line, 
positive for pleural invasion. B. Relationship between existence of lymphoid 
follicles and overall survival. Solid line, negative for lymphoid follicles; 
dotted line, positive for lymphoid follicles. C. Relationship between existence 
of regulatory T cells and overall survival. Solid line, negative for regulatory T 
cells; dotted line, positive for regulatory T cells. 
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Table 1. Patient characteristics 
Total 72 
Gender  
	 male 67 
	 	 	 female 5 
Smoking index (packs/year)  
	 <30 10 
	 	 	 ≥30 62 
Interstitial pneumonia  
absent 50 
present 	 	 	 	 	 	  22 
SCC  
  ≤1.6 39 
	 	 	 	   >1.6 32 
	 	 	 	 	 unknown 1 
Neo-adjuvant therapy  
+ 9 
- 63 
Type of resection  
sublobar resection 9 
lobectomy or more 63 
Pleural invasion  
           	 	 	    0 51 
1 8 
2 3 
3 10 
Lymphatic invasion 	        
0 60 
	 	   	         1 12 
Vascular invasion  
	 	 0 28 
 28 
	 	 	 1 44 
Pathological stage  
      0 1 
               IA 20 
	 	 	 	 IB 15 
                IIA 11 
                IIB 8 
               IIIA 17 
PD-L1 expression  
       0% 19 
1-49% 36 
≥50% 8 
unknown 9 
Postoperative complication  
+ 24 
- 48 
Status  
alive 39 
	 	 	 dead 31 
	 	 	 unknown 2 
SCC, squamous cell carcinoma related antigen; PD-L1, programmed 
death-ligand 1 
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Table 2. Relationship between lymphoid follicles and regulatory T cells 
  Tregs  PD-L1  
  absent present P value 0 0 P value 
Lymphoid 
follicle 
absent 59 0 
 
13 13 
 
 present 5 8 <0.001 6 6 0.16 
Tregs, regulatory T cells; PD-L1, programed death-ligand 1 
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Table 3. Univariate and multivariate analysis of overall survival 
 Univariate Multivariate 
 HR 95% CI P-value HR 95%CI P-value 
Gender         
(male / female） 0.87 0.27 4.75 0.87     
PS         
(0/≥1) 2.26 0.79 6.49 0.13     
BI         
(<600/≥600) 5.59 0.76 41.0 0.091     
IP         
(-/+) 1.90 0.92 3.94 0.082     
SCC         
(≤1.6/>1.6) 1.65 0.81 3.35 0.17     
pStage         
(I/II+III) 2.54 1.19 5.41 0.012 1.51 0.66 3.47 0.33 
Neo-adjuvant 
therapy 
 
   
    
(-/+) 0.63 0.19 2.07 0.45     
Operation         
(limited/lobectomy 
or more) 
0.94 
0.33 2.71 0.91 
    
Postoperative com
plication 
 
   
    
(-/+) 1.48 0.72 3.02 0.29     
Pleural invasion         
(-/+) 2.54 1.24 5.22 0.011 2.26 1.08 4.74 0.031 
Lymphatic invasion         
(-/+) 1.64 0.70 3.84 0.28     
Vascular invasion         
(-/+) 2.43 1.08 5.46 0.031 1.60 0.68 3.79 0.28 
TIL grade         
 31 
(0/1-2) 1.03 0.49 2.14 0.94     
(0-1/2) 0.97 0.45 2.06 0.93     
T/B lymphocyte 
ratio 
 
   
    
(<1/≥1) 0.94 0.46 2.17 0.99     
PD-L1         
(0%/≥1%) 0.78 0.34 1.77 0.55     
(0-49%/≥50%) 1.97 0.74 5.20 0.17     
Lymphoid follicles         
(-/+) 3.33 1.50 7.43 0.003 2.61 1.11 6.01 0.026 
 
HR, hazard ratio; CI, confidential interval; PS, performance status; BI, Brinkman 
index (smoking index); IP, interstitial pneumonia; SCC, squamous cell 
carcinoma related antigen; pStage, pathological stage; TIL, tumor-infiltrating 
lymphocyte; PD-L1, programmed death ligand 1 
 
 
